Source:http://linkedlifedata.com/resource/pubmed/id/12625958
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-3-10
|
pubmed:abstractText |
One of the fundamental principles that underlies tissue-engineering strategies using cell transplantation is that a newly formed tissue must acquire and maintain sufficient vascularization in order to support its growth. Enhancing angiogenesis through delivery of growth factors is one approach to establishing a vascular network to these tissues. In this study, we tested the potential of bone marrow stromal cells (BMSCs) to modulate the growth and differentiation activities of blood vessel precursors, endothelial cells (ECs), by their secretion of soluble angiogenic factors. The growth and differentiation of cultured ECs were enhanced in response to exposure to BMSC conditioned medium (CM). Enzyme-linked immunosorbent assays demonstrated that both mouse and human BMSCs secreted significant quantities of vascular endothelial growth factor (VEGF) (2.4-3.1 ng/10(6) cells per day). Furthermore, eliminating the activity of BMSC-secreted VEGF with blocking antibodies completely blocked the CM effects on cultured ECs. These data demonstrate that human BMSCs secrete sufficient quantities of VEGF to enhance survival and differentiation of endothelial cells in vitro, and suggest they may be capable of directly orchestrating angiogenesis in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1076-3279
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-103
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12625958-Bone Marrow Cells,
pubmed-meshheading:12625958-Cell Differentiation,
pubmed-meshheading:12625958-Cell Survival,
pubmed-meshheading:12625958-Endothelial Growth Factors,
pubmed-meshheading:12625958-Endothelium, Vascular,
pubmed-meshheading:12625958-Humans,
pubmed-meshheading:12625958-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:12625958-Lymphokines,
pubmed-meshheading:12625958-Neovascularization, Physiologic,
pubmed-meshheading:12625958-Stromal Cells,
pubmed-meshheading:12625958-Tissue Engineering,
pubmed-meshheading:12625958-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12625958-Vascular Endothelial Growth Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells.
|
pubmed:affiliation |
Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, Michigan 48109-1078, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|